Eastern Cooperative Oncology Group

This study tested whether adding a lab-made antibody (C225) to standard chemotherapy (cisplatin) helps people with advanced head and neck cancer that has spread or come back. About 300 adults with incurable disease took part. The goal was to see if the combination worked better t…